Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Milestone Pharmaceuticals granted 33,000 stock options to one new employee under its 2021 Inducement Plan, per Nasdaq Listing Rule 5635(c)(4). The options carry a $0.72 exercise price — equal to the November 2 closing price — and vest over four years with a one-year cliff.
Key figures
- Vesting
- 4 years, 25% at one-year anniversary, remainder in 36 monthly installments
- Exercise price
- 0.72
- Options granted
- 33000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.